Human genomes hold a record of the evolutionary forces that have shaped our species. Advances in DNA sequencing, functional genomics, and population genetic modeling have deepened our understanding of human demographic history, natural selection, and many other long-studied topics. These advances have also revealed many previously underappreciated factors that influence the evolution of the human genome, including functional modifications to DNA and histones, conserved 3D topological chromatin domains, structural variation, and heterogeneous mutation patterns along the genome. Using evolutionary theory as a lens to study these phenomena will lead to significant breakthroughs in understanding what makes us human and why we get sick.
Introduction
Understanding the evolution of the human genome is a tantalizing goal. Accurately decoding the biological programs encoded in the human genome would reveal molecular answers to fundamental questions about human origins and the genetic basis for human-specific traits. Studying the evolutionary and demographic history of our species also has great promise to reveal how and why modern humans get sick. The human genome has been shaped by evolutionary pressures that, in many cases, no longer reflect the circumstances of most humans, and this mismatch between our genes and our environment can lead to disease [1, 2] .
In spite of immense progress since the sequencing of the first human genome more than 10 years ago, there is still much we do not understand about the evolution of the human genome. Recent statistical and experimental advances and the sequencing of thousands of human genomes from diverse populations have revealed significant complexity in classical topics in human population genetics, including the dynamics of selection across human populations and closely related species [3] [4] [5] [6] , the determinants of variation in mutation rates [7, 8] , inference of ancient human population histories [9, 10] , and how variants, in particular rare variants, contribute to phenotypes [11] [12] [13] . Perhaps the most dramatic result in this field over the past five years has been the sequencing of ancient DNA from archaic hominins, like Neanderthals and Denisovans [14, 15] , and the comprehensive demonstration of admixture between the ancestors of modern humans and several archaic hominin groups [16] [17] [18] [19] [20] . Each of these topics has been covered in recent comprehensive reviews (referenced above) and a recent issue of this journal [21] , so here we highlight several additional genetic, environmental, and demographic factors influencing human genome evolution that we believe deserve further attention (Figure 1 ).
How do gene regulatory processes influence human genome evolution?
In the 40 years since King and Wilson hypothesized that phenotypic differences between closely related species were driven by gene regulatory changes, considerable support has been found for the importance of cis-regulatory elements (CREs), such as promoters and enhancers, in human evolution [22, 23] and disease [24, 25] . The recent ability to map gene expression, transcription factor (TF) binding sites, and histone modifications genome-wide in many tissues and species [26] [27] [28] has revealed that, while gene expression is generally conserved within similar tissues across species [29] , CREs experience rapid turnover [30] [31] [32] . For example, a recent study of liver promoters and enhancers across 20 mammalian species found that 25% of a species' enhancers and 10% of its promoters were unique, even when the underlying sequence was deeply conserved [33]; similar results were found for limb CREs across human, macaque, and mouse [34] .
There is still much to be learned about the evolution of regulatory sequence, in particular about its dynamics across tissues, species, and different classes of CREs, and how selection acts on these elements. For example, transposable elements (TEs) have helped reprogram gene regulatory networks in tissues relevant to pregnancy in humans and other mammals [35] . In contrast, TEs have made only a modest contribution to the evolution of new CREs in the liver [33] . This suggests that, while fast turnover of CREs and conserved gene expression are common features of mammalian genome evolution, different evolutionary dynamics and pressures act on CREs active in different tissues. It is likely that the regulatory landscapes of some tissues are more conducive to turnover than others; for example, tissues with greater phenotypic diversity across species, like those involved in pregnancy, may be more susceptible to TE-based rewiring. The maintenance and modification of these regulatory processes and their influence on genome evolution requires further investigation.
Integrating genome-wide maps of CREs, TF binding, and expression with recent advances in techniques for determining in vivo chromatin conformation of DNA [36] may provide a promising framework for modeling the influence of gene regulation on genome evolution. A recent study of chromatin looping in multiple human and mouse tissues found significant conservation of gene activity within local topological domains across cells and species [37] . These results suggest that, as is true for proteins, the 3D structure of regulatory neighborhoods maybe more deeply conserved and important for function than the sequence-level conservation of individual CREs. Integrating data about genome structure and CREs across many individuals will likely lead to better models of regulatory sequence evolution and how selection acts on gene expression across evolutionary time and tissues.
How do chemical modifications to DNA and histones constrain human genome evolution?
The human body contains hundreds of different cell types with diverse forms and functions, yet each cell contains (essentially) the same genome. The past decade has seen increasing appreciation for the role of DNA and histone modifications, such as methylation and acetylation, in the diverse gene expression programs observed across different cell types within complex organisms [38] [39] [40] . These modifications can be influenced by environmental factors [41] and in some cases inherited across generations, though the extent of trans-generational inheritance in humans is still unclear [42] .
In spite of extensive work linking these modifications to nearly all processes of development, aging, and disease [39, [43] [44] [45] , the influence of these modifications on patterns of genome sequence evolution has received comparatively little attention. For example, the extent to which the potential for chemical modification places constraint on DNA sequence patterns, e.g, CpG sites, is not resolved. Several recent studies have explored the degree of conservation of DNA and histone modifications across humans and closely related species [31,33,34, [46] [47] [48] ; changes to the modification status of orthologous regions are common between closely related species and, for DNA methylation, there is a positive correlation between sequence variation and promoter methylation changes. However, even in the presence of deep sequence conservation, many sites show differential modification. Much work remains to model the evolution of these modifications between individuals and species and to identify associated sequence constraints (or lack thereof). Understanding the evolution of these modifications may help resolve debates about whether specific modifications are causal or are the result of other processes like TF binding and transcription [49] .
How should interactions between multiple genetic variants and phenotypes be modeled?
The majority of human phenotypes of clinical and evolutionary interest are specified by multiple loci across the human genome. Developing models that account for relationships between multiple genetic variants and phenotypes will be critical to fully dissecting the evolution and complex genetic architecture of most human traits. For example, pleiotropywhen a locus influences multiple independent traits-is found throughout the human genome; however, there is still considerable uncertainty about its prevalence and influence on genome evolution [50] [51] [52] [53] . Similarly, epistasis-a non-additive interaction between genetic variants-is common in model organisms, but its influence on human traits has been controversial due to a number of technical and biological factors that can confound current tests for interactions between variants [54, 55] . Each of these areas is in need of new statistical approaches that update existing models to make full use of the wealth of genotype and phenotype data that have become available in the last five years.
What are the causes and effects of mutational biases along the human genome?
There is considerable variation in the rate and pattern of substitution along the human genome. Failure to account for these biases can confound tests for selection, complicate demographic inference, and weaken power in association tests [7] . One of the most potentially influential mutational biases is a recombination-associated process called GCbiased gene conversion (gBGC). gBGC results from a slight preference for G/C alleles in the mismatch repair machinery that has the potential to promote the maintenance of deleterious alleles [57] . The action of gBGC is widespread in human populations and across diverse species [58] [59] [60] . Genome-wide modeling of gBGC has demonstrated differences in its strength across the human and chimpanzee lineages [59] and between different human populations [61, 62] .
The evolution and effects of gBGC are intimately tied to the dynamics of recombination, which vary considerably in rate along the genome within human populations and between closely related species [63] . Recombination patterns influence many drivers of genome evolution, including the efficacy of selection, mutation rates, and the accumulation of deleterious mutations [64, 65] . In humans, the fast evolving PRDM9 protein directs recombination to specific hotspots based on the occurrence of a GC-rich motif [66] . Using modern and archaic genome sequences, modeling suggests that gBGC degrades the PRDM9 motif over time and that this may drive the rapid turnover of the recombination landscape in human populations [67] .
gBGC is only one of several sources of mutation rate variation that are not well understood [7] . Recent direct estimates from trios indicate that the human germline mutation rate is only half of what is expected from phylogenetic estimates [68] , and analysis of whole genome sequence data suggests the evolution of population-specific mutation rates since the divergence of Europeans and Asians [69] . These results underscore the need for further study of the dynamics and causes of human mutation rate variation across evolutionary time and genomic space. We need to develop high-resolution maps of mutation rates in different populations, better models of how it interacts with selection and recombination, and most importantly, a deeper understanding of its effects on organismal fitness.
What are appropriate models for the evolution and functional impact of structural variation?
The initial comparison of the draft human and chimpanzee genomes identified approximately 35 million single nucleotide polymorphisms (SNPs), 5 million small insertions and deletions (indels), and hundreds of larger structural variants (SVs). Indels and large SVs account for far more nucleotide differences between the human and chimpanzee genomes than SNPs [70] and have restructured the genomes of great apes [71] . Recent work on de novo rates of indels and SVs in human populations found that structural changes are much more rare and occur at lower frequency than SNPs; nonetheless, they influence an average of 4.1 kilobases per generation, which is 91 times more than de novo substitutions [72] . Indels and large SVs (including copy number variants, inversions, and other genomic rearrangements) are more likely to cause disease and have been hypothesized to have a greater influence on recent human evolution than SNPs [73, 74] . Indeed, many human-and population-specific SVs have been tied to human-specific phenotypes [75] , e.g., humanspecific deletion of a conserved enhancer of the androgen receptor gene may be responsible for the lack of penile spines in humans [76] . It has also been suggested that de novo creation of new genes is more common than previously appreciated; tens of new human-specific genes have been detected, with particular enrichment for expression in the brain and testes [77, 78] .
In spite of the potential importance of indels, large SVs, and new genes to phenotypic differences between human individuals and between closely related species, they have received considerably less attention in evolutionary modeling and testing for association with disease than SNPs. Developing appropriate models for the evolution of indels and SVs faces several challenges including the difficulty of accurately identifying them in short read sequencing data, the diversity of mechanisms that generate them, and their highly heterogeneous mutation rates and distributions along the genome [72, 79] . Nevertheless, it is essential to develop evolutionary models akin to those in common use for testing hypotheses about patterns of single nucleotide variant evolution and association with disease for indels and SVs. Sufficiently accurate maps of these events across hundreds of humans are now becoming available [79, 80] ; these data should facilitate the development of new modeling approaches.
How can we efficiently connect human-specific genomic changes to phenotypes?
Sequencing the genomes of thousands of humans, several archaic humans, and our closest great ape relatives has revealed thousands of loci in the human genome that have experienced accelerated evolution on the human lineage and hundreds more with signatures of recent positive selection [81] [82] [83] . These loci hold the promise of explaining much of human-specific biology, and many hypotheses have been proposed about their effects [75] . However, beyond a handful of successes that involved detailed experimental validation [76, [84] [85] [86] [87] [88] , connecting these mutations to effects on human phenotypes has been difficult. The first obstacle comes from the fact that the vast majority of these regions are non-coding and have minimal functional annotation. Furthermore, most human-specific traits have complex genetic architectures in which many coding and non-coding loci influence the phenotype [89] . Finally, appropriate model systems in which to test potential effects of mutations are not available for many phenotypes, and it is challenging to test variants in a high throughput manner in available systems.
Algorithmic and experimental innovations paired with increases in available phenotype and functional genomic data will significantly increase the pace with which human-specific variants can be characterized. For example, algorithms that integrate diverse functional, evolutionary, and DNA sequence data have shown that many human accelerated regions are developmental gene regulatory enhancers, with particular enrichment for brain activity [81, 88, 90] . As our understanding of how non-coding mutations influence gene expression and function improves [91] , so will the accuracy and specificity of hypotheses about the effects of these regions on human-specific phenotypes.
Over the past ten years, genome-wide association studies (GWAS) have identified hundreds of variants associated with complex diseases [92, 93] . These studies provide insight into the functions encoded in specific regions of the genome that can inform evolutionary questions. However, the majority of human-and population-specific variants have not been associated with functions. The recent integration of large databases of electronic health records (EHRs) linked to patient genotypes [94] provides a new approach to this problem. Thousands of phenotypes can be algorithmically derived from EHRs and then simultaneously tested for association with the loci of interest across thousands of individuals in a phenome-wide association study (PheWAS) [95] . As EHR databases grow and sequencing decreases in price, the PheWAS approach will enable efficient testing of hypotheses about the effects of mutations of evolutionary interest.
Finally, new technologies, including directed stem cell differentiation, massively parallel reporter assays [96] , and CRISPR gene editing [97] , will facilitate faster exploration of the mechanisms driving phenotypic associations in models that closely resemble the in vivo human context.
Conclusion
Understanding how evolutionary processes produced the human species and how developmental programs are encoded in the human genome is of great importance to basic and clinical science. The evolutionary history of the human genome is directly relevant to our ability to anticipate and treat human disease [1] . In this review, we have highlighted several research areas that have potential to significantly deepen our knowledge of human genome evolution over the next few years, but our list is not exhaustive. Many other areas, including the evolutionary study of human-microbe interactions [98, 99] and experimental evolution [100] , are poised for breakthroughs. We are also eager to see how recent technical advances in long-read genome sequencing and single cell analysis will change our understanding of evolutionary processes. Ultimately, continued analysis of the human genome in an evolutionary framework will further reveal the genetic origins of humanspecific biology and improve our understanding of the etiology of human disease. Many areas of ongoing research in genomics have not been fully integrated into models of genome evolution. In this article, we discuss how study of several emerging topics (bold) in an evolutionary context will enrich our understanding of human evolution.
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